Virtual Gut-Directed Hypnotherapy for Crohn’s Disease

 

100% online

The results all ticked YES for improvement

By Trish Pellen (CHA Director) & Justine Lette (HNZ Director)

What a Recent Feasibility Study Found

Interest in mind–body approaches for digestive health continues to grow, particularly for chronic conditions like Crohn’s disease. A recent feasibility study published in PubMed explored whether virtually delivered gut-directed hypnotherapy is practical, acceptable, and helpful for people already living with Crohn’s disease.

You can view the study here:
https://pubmed.ncbi.nlm.nih.gov/37531719/

This article explains what the researchers did, what they found, and what it means in practical terms.





First, what is a feasibility study?

A feasibility study is not designed to prove that a treatment cures or directly improves a specific symptom. Instead, it asks a different question:

Is this intervention practical, acceptable, and workable for patients?

Researchers look at things like:

  • Can people complete the programme?

  • Do they engage with the treatment?

  • Is it safe and manageable?

  • Do participants report overall improvements in wellbeing?

  • Can the process be delivered reliably?

In this case, the focus was on baseline nervous system functioning and overall wellbeing, including quality of life, stress, anxiety, and major personal symptom burden.

How the study was designed

This was a randomised feasibility trial involving adults diagnosed with Crohn’s disease. Importantly, participants were already receiving their usual medical care. Hypnotherapy was added as a complementary intervention.

Key features of the study:

  • Delivered at a tertiary hospital

  • Conducted between 2020 and 2021

  • 100% online delivery

  • Seven-week programme of gut-directed hypnotherapy

  • Participants assessed at five time points:

    • Baseline

    • Post-intervention

    • 3-month follow-up

    • 6-month follow-up

    • 12-month follow-up

This design allowed researchers to observe both short-term and longer-term patterns.

Participation and completion rates

Engagement was strong, which is one of the most important outcomes in feasibility research.

  • 33 people were invited

  • Most participants completed therapy sessions

  • Around 76% completed the full 12-month assessment period

  • About 88% attended all therapy sessions

  • 95% reached the post-intervention stage

  • 73% reported being extremely satisfied

  • Around 60% experienced technical difficulties, mostly related to online delivery, yet satisfaction remained high

These numbers indicate strong acceptability, even with the challenges of virtual delivery.

What outcomes were observed?

Because this was a feasibility study, the results focus on overall wellbeing rather than specific symptom measurements.

Participants reported:

  • Improved quality of life

  • Reduced stress and emotional burden

  • Positive changes in their main individual symptom concerns

  • High satisfaction with treatment

  • Sustained benefits at 3, 6, and 12-month follow-ups

Notably, these improvements occurred without changes to diet or nutrition, and without replacing medical care. Hypnotherapy functioned as an additional supportive intervention.

Why virtual delivery matters

This study is especially relevant because all sessions were conducted online. During the COVID period, many healthcare providers needed remote solutions. The findings suggest that:

  • Hypnotherapy can be delivered effectively online

  • Patients remain engaged long-term

  • Clinical settings can integrate virtual mind–body interventions

This expands accessibility for people who cannot easily attend in person.

Study integrity and credibility

Several factors strengthen the reliability of the findings:

  • Conducted in a hospital setting

  • Participants had medically diagnosed Crohn’s disease

  • Objective data collection across multiple time points

  • No declared conflicts of interest

  • Long follow-up period of 12 months

These elements help confirm the study was conducted with appropriate clinical oversight.

What does this mean for people with Crohn’s disease?

The study does not claim that hypnotherapy treats Crohn’s disease directly. Instead, it demonstrates that:

  • Gut-directed hypnotherapy is feasible and acceptable

  • Patients engage with and complete treatment

  • Many experience meaningful improvements in overall wellbeing

  • Benefits can continue long after treatment ends

  • Virtual delivery is practical in real healthcare settings

In other words, hypnotherapy may be a valuable supportive intervention alongside standard medical care, particularly for nervous system regulation and quality of life.

Why the gut-brain connection matters

Gut-directed hypnotherapy works through the gut–brain axis, influencing:

  • Nervous system regulation

  • Stress response

  • Sensory processing

  • Emotional reactivity

  • Perception of symptoms

For chronic digestive conditions, where stress and physiological responses interact closely, this mind–body pathway is highly relevant.

This feasibility study provides encouraging evidence that virtual gut-directed hypnotherapy is practical, well accepted, and associated with improvements in overall wellbeing for adults with Crohn’s disease.

It does not replace medical treatment, but it highlights the potential value of integrating nervous system-focused therapies into comprehensive care.

As research continues, larger trials will help clarify exactly which symptoms improve most and how these changes occur. For now, the study offers a strong foundation showing that this approach is both workable and beneficial for many patients.

Reference: PubMed Study https://pubmed.ncbi.nlm.nih.gov/37531719/

Find a Gut Directed Hypnotherapist and Training here: https://www.pellenandpalmer.com/gut-directed-hypnotherapy


 
 
  • The study examined whether gut-directed hypnotherapy delivered online is practical, acceptable, and beneficial for adults with diagnosed Crohn’s disease. It focused on feasibility, patient engagement, and overall wellbeing, including quality of life and stress.

  • The study found that most participants reported improved quality of life and wellbeing after completing the virtual hypnotherapy programme. While it did not measure specific symptom changes, results suggest it may be a helpful supportive therapy alongside medical treatment.

  • Participants completed a seven-week gut-directed hypnotherapy programme delivered entirely online. Researchers assessed outcomes at baseline, after treatment, and again at 3, 6, and 12 months to track longer-term effects.

  • Most participants completed their sessions, and around 76% finished the full 12-month follow-up period. High completion and satisfaction rates showed that virtual hypnotherapy is both practical and well accepted by patients with Crohn’s disease.

  • No. The study looked at hypnotherapy as a complementary therapy, not a replacement for medical care. Participants continued their usual treatments, and hypnotherapy was explored as an additional way to support nervous system regulation and quality of life.

Find a Gut Directed Hypnosis Professional here - https://www.pellenandpalmer.com/gut-directed-hypnotherapy Scroll to the bottom of the page.

P&P

Trish Palmer and John Pellen.

https://www.pellenandpalmer.com
Next
Next

Online Gut-Directed Hypnosis for IBS: What This Major Study Reveals